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EPI Update for Friday, February 15, 2008 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
  
Items for this week’s EPI Update include: 
  
•        Histoplasmosis investigation update 
•        Ciprofloxacin-resistant meningococcal bacteria 
•        Influenza update 
•        Shingles (Herpes Zoster) 
• Meeting announcements and training opportunities  
  
Histoplasmosis investigation update  
The investigation at Terrace Hill, the Governor’s Mansion, continues. As of 
Wednesday night, 131 calls have come in to the public health call center from the 
public concerning the situation. Neither the epidemiologic, nor the environmental 
investigation have indicated that exposure to histoplasmosis occurred on any day 
other than Nov. 29, 2007. Initial epidemiologic information indicates the evening 
of the 29th as the most likely time of exposure. More than 200 persons have 
been interviewed and more than 105 have submitted samples for laboratory 
testing. Interviewing and analysis of data is ongoing and environmental test 
results are pending. 
  
Ciprofloxacin-resistant meningococcal bacteria 
The Minnesota and North Dakota Departments of Health report that there have 
been three meningococcal cases over the past year (two cases in Minnesota in 
January 2008 and one case in North Dakota in January 2007), in which the strain 
was found to be resistant to quinolone antibiotics (like ciprofloxacin). These are 
the first known quinolone-resistant meningococcal cases in the United States.  
  
Meningococcus (Neisseria meningitidis) can cause meningitis, sepsis 
(bloodstream infections), pneumonia, and other serious infections. Quinolones 
are commonly given as prophylaxis to those in close contact to patients with 
 meningococcal disease to reduce their risk of becoming ill (rifampicin may also 
be used). Meningococcal infections are uncommon in Iowa; usually about 25 
cases each year in Iowa, and typically the largest number of cases occur 
between January and April.  
  
Meningococcal vaccine is recommended for children ages 11-18 years and 
college freshman living in dormitories, as well as others who have medical 
conditions or live in specific geographical areas that put them at high risk for 
meningococcal disease. This vaccine covers four common serogroups of 
meningococcus. However it does not include serogroup B, the serogroup that 
occurred in these quinolone-resistant cases.  
  
Influenza update 
Influenza activity in Iowa is now widespread. The percentage of school absences 
has nearly doubled since December. Flu-related hospitalizations have also 
increased. Iowa is one of 31 states where flu activity has reached a widespread 
level. For more information visit www.idph.state.ia.us/adper/iisn
  
It's not too late to get a flu shot. Vaccination now can still provide protection for 
the remainder of the flu season, which can last as late as May. In addition, simple 
steps like frequent hand washing and not coughing or sneezing on others can 
help prevent the spread of influenza. Most importantly, those who are ill should 
stay home from work or school.  
  
Shingles (Herpes Zoster) 
Shingles is a painful skin condition caused by the varicella zoster virus (VZV), the 
same virus that causes chickenpox. After a person recovers from chickenpox, the 
virus can stay in the body. Usually the sequestered virus does not cause any 
problems, however, the virus can reappear years later, causing shingles.  
  
Shingles cannot be passed from one person to another. However, the virus that 
causes shingles, VZV, can be spread from a person with active shingles to a 
person who has never had chickenpox; that person would develop chickenpox, 
not shingles.  
  
A person with shingles can spread the virus when the rash is in the blister phase. 
Once the blisters have developed crusts, the person is no longer considered 
contagious. A person is not infectious before blisters appear or with post-herpetic 
neuralgia (pain after the rash is gone). The risk of spreading shingles is low if the 
rash is kept covered, thus people with shingles should keep the rash covered, 
not touch or scratch the rash, and wash their hands often. For more information 
visit www.cdc.gov/vaccines/vpd-vac/shingles/dis-faqs
  
Zostavax, a vaccine for shingles was licenced in 2006 for use in adults age 60 
and older. In clinical trials, the vaccine prevented shingles by 50%, and reduced 
the pain associated with shingles. For more vaccine information visit 
www.cdc.gov/vaccines/pubs/vis/downloads/vis-shingles.pdf   
  
Meeting announcements and training opportunities 
None 
  
Have a healthy and happy week! 
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